Quantum Genomics to receive up to $18.5 million in upfront and milestone payments plus double-digit royalties on sales DongWha Pharm to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in South Korea PARIS, Dec. 02, 2020 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical […]